Friday February 21, 2020
Home Business Vineyards in ...

Vineyards in Oregon

Oregon has increasingly received international acclaim fir vineyards and these days the Willamette Valley is the center of a wine region

0
//
Oregon
Oregon vineyards in Oregon along with its own Estate Vineyard, which with its adjacent winery and tasting rooms boasts some spectacular views. Pixabay

Oregon’s wet weather and short summers meant people used to doubt whether the state could ever successfully produce wine. That was 30-plus years ago, but since then it has increasingly received international acclaim and these days the Willamette Valley is the center of a wine region that is world-famous for some of America’s best Pinot Noir.

Here are 10 of the top vineyards in Oregon to visit: 

  1.       DOMAINE DROUHIN (6750 Breyman Orchards Road, Dayton OR 97114, 503-864-2700) is among Oregon’s very finest vineyards. Its motto is “French soul, Oregon soil” and it is owned by the Drouhin family. For the fourth generation, the wines are made using similar techniques to the family’s wines that are produced in Burgundy, France. More information can be found at www.domainedrouhin.com or @DrouhinOregon on Twitter.
  2.       TYEE WINE CELLARS (26335 Greenberry Road, in Corvallis OR 97333, 541-753-8754) can be found one the Buchanan Family Century Farm, which was founded in Willamette Valley over 120 years ago near Corvallis.  More information can be found at www.tyeewine.com or @TyeeWine.

3.   WINTER’S HILL VINEYARD (6451 Northeast Hilltop Lane, Dayton OR 97114, 503-864-4592) conducts tastings in the winery which is surrounded by a landscape of forest and fields.

4.   WILLAMETTE VALLEY VINEYARDS incorporates food and wine pairings so that visitors can discover local ingredients along with the wines, which are inspired by the wines of Tuscany among others. Pinots are featured with food like steelhead salads through roasted lamb to short ribs.

Find out more by visiting www.wvv.com.

Oregon
Oregon is one of the very finest vineyards. Its motto is “French soul, Oregon soil” and it is owned by the Drouhin family. Pixabay

5.   KING ESTATE WINERY (80854 Territorial Highway, Eugene OR 97405, 541-942-9874) was discovered by Ed King in 1990. In the next four years over 100 acres had been planted to create the most diverse soil vineyard ever created in Oregon. Organic winemaking processes enhance the complex fruit flavors and help create wines of great acidity, with structure and minerality to match. Learn more at www.kingestate.com or @KingEstate.

6.   CHERRY HILL WINERY (7867 Crowley Road, Rickreall OR 97371, 503 623-7867) nestles in the Eola Hills of the Willamette Valley. This is a boutique winery where super-premium Pinot Noir is produced by hand.  Find out more at www.cherryhillwinery.com.

7.   YAMHILL VALLEY VINEYARDS (16250 SW Oldsville Road, McMinnville OR 97128, 503 843-3100) is the oldest winery in the McMinnville American Viticultural Area.  It grows, produces and bottles all its own grapes on a 150-acre estate in the foothills of the Coast Range Mountains. The grapes here are the three Pinots – Noir, Gris, and Blanc – Chardonnay, and Riesling. Find out more at www.yamhill.com.

8.   DE PONTE CELLARS (17545 NE Archery Summit Road, Dayton OR 97114, 503 864-3698) is on the site of one of the Willamette Valley’s oldest vineyards.  The first Pinot Noir from here was released to critical acclaim back in 2001. As well as Pinot Noir, De Ponte is famed for its Melon grape, which is rare throughout the US.  

Oregon
WINTER’S HILL VINEYARD conducts tastings in the winery which is surrounded by a landscape of forest and fields, in Oregon. Pixabay

9.   YOUNGBERG HILL VINEYARDS (10660 SW Youngberg Hill Road, McMinnville OR 97128, 503 472-2727) began farming organically in 2003 and continues to move further in that direction. It is a small, producer of both Pinot Noir and Pinot Gris.

ALSO READ: Mindfulness can Reduce Opioid Cravings, Study Says

10.   PENNER-ASH WINE CELLARS (15771 NE Ribbon Ridge Road, Newberg OR 97132, 503 554-5545) sources its grapes from the best Oregon vineyards in Oregon along with its own Estate Vineyard, which with its adjacent winery and tasting rooms boasts some spectacular views. Find out more at www.pennerash.com or @pennerash.

Next Story

American Biotech Company Works with Chinese Officials to Test Drug Against Coronavirus

Trials to Test Ebola Drug's Potential to Prevent, Treat Coronavirus

0
Coronavirus
An American biotech company says it is working with Chinese authorities to determine the efficiency of a drug that can fight coronavirus. Pixabay

By Natalie Liu

An American biotech company says it is working with Chinese authorities to determine whether the antiviral drug remdesivir may provide an effective treatment for victims of the fast-spreading coronavirus known as COVID-19. The Chinese researchers hope to have the answer by May 1.

Officials of Gilead Sciences, which invented remdesivir as a treatment for Ebola and another disease, told VOA the company has initiated two clinical trials among infected patients “to determine the safety and efficacy of remdesivir as a potential treatment for the coronavirus.”

The trials have been warmly welcomed in China, where the nation’s official news agency celebrated the launch with a front page article. Anxious Chinese citizens have noted that the four syllables of remdesivir resemble the phrase as renmin-de-xi-wang, or people’s hope.

Coronavirus
A medical worker holds a thermometer to check a passenger’s temperature at a checkpoint as the country is hit by an outbreak of the coronavirus in Susong County, Anhui province, China. VOA

There are also more scientific reasons to be hopeful, including the case of an American coronavirus patient who experienced a speedy recovery in January, just 24 hours after being given remdesivir. Before the drug was administered, his symptoms had shown signs of worsening.

The first trial began enrolling patients on February 6, said a written statement from Gilead, which says it has provided China with “enough doses of remdesivir to treat up to 500 trial participants.” A Shanghai-based media outlet reported having seen a customs clearance form showing that 2,843 boxes of remdesivir arrived in Beijing on February 4.

The next day, a conference dedicated to the official launch of clinical trials took place at the Jinyintan Hospital in Wuhan, led by Dr. Bin Cao and his colleague Dr. Chen Wang, both top scientists practicing at the China-Japan Friendship Hospital in Beijing. Jinyintan Hospital has been treating some of the most critical COVID-19 cases since the outbreak began.

Gilead confirmed the trials are “being coordinated by the China-Japan Friendship Hospital in Beijing.” A filing registered with the U.S. National Library of Medicine lists the Beijing-based Capital Medical University as the trial’s main sponsor and Cao, a specialist in pulmonary critical care at the China-Japan Friendship Hospital, as the “responsible party.”

Research shows promise

In a scientific paper based on animal studies and published last week, scientists found remdesivir to be effective both for the prevention and treatment of the deadly Middle East Respiratory Syndrome coronavirus (MERS-CoV,) which is known to bear resemblances to COVID-19.

“Remdesivir prevented disease when administered before infection and improved the condition of macaques [monkeys] when given after the animals already were infected,” said scientists at the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories in Hamilton, Montana.

Coronavirus
A medical worker calls his colleague inside an isolated ward at Jinyintan Hospital in Wuhan, the epicenter of the novel coronavirus outbreak, in Hubei province, China. VOA

Dr. Emmie de Wit, Chief of the Molecular Pathogenesis Unit in the Laboratory of Virology at the Montana facility, told VOA that she and her colleagues conducted their studies and submitted their results for review “well before the world knew of the outbreak in Wuhan.” De Wit said she and her colleagues learned about the coronavirus outbreak on Dec. 31.

Wuhan trials

In the Wuhan study, participants are divided into two groups — those “who have developed more severe clinical manifestations” such as requiring oxygen, and those who do not require oxygen.

“Patients will receive 10 days of intravenously administered remdesivir. The primary endpoint of both studies involves clinical improvement 28 days after treatment,” according to Gilead. Cao reported that 200 mg of remdesivir would be given to a group of patients on day one, followed by 100 mg once-daily “maintenance doses” for nine additional days.

Also Read- Russia Allows Chinese Nationals with Business Visas Despite Entry Ban

Patients in a control group were to be given placebos. To ensure objectivity, the identities of the patients receiving the placebos are masked from the participants, care providers, researchers and outcome assessors.

The researchers say they aim to complete the trials by April 3 and evaluate the results by May 1. (VOA)